|
Quotes & Info
|
| CTIC > SEC Filings for CTIC > Form 8-K on 7-Jul-2009 | All Recent SEC Filings |
7-Jul-2009
Other Events
On July 7, 2009, Cell Therapeutics, Inc. (the "Company") announced that it had requested and the European Medicines Agency (EMEA) has agreed to an oral explanation in support of the OPAXIO Marketing Authorization Application (MAA) in September 2009, which extends the review for the Committee for Medicinal Products for Human Use (CMPH) opinion on approval until the fourth quarter of 2009.
|
|